Injections

Injectable Range — Saturn Formulations PCD Pharma Franchise

Injectable pharmaceuticals represent the highest-quality, highest-value, and most technically demanding category of pharmaceutical manufacturing. They are the therapeutic backbone of hospital medicine — from antibiotics administered intravenously for life-threatening infections to pain management by intramuscular route, and fluid and electrolyte correction through large-volume IV infusions. Saturn Formulations, a WHO-GMP and ISO-certified pharmaceutical manufacturer established in 2012, has invested in state-of-the-art sterile manufacturing infrastructure to produce a comprehensive range of Injectable Pharmaceuticals including small-volume parenterals (ampoules and vials), lyophilised powder-for-injection vials, and large-volume parenteral infusions — providing PCD Pharma Franchise partners with access to the institutional pharmaceutical supply market across India's rapidly expanding hospital sector.

Our injectable manufacturing facility operates under Grade A/B cleanroom conditions — the international standard for aseptic pharmaceutical manufacturing — with continuous environmental monitoring, validated sterilisation cycles, and comprehensive quality systems that meet the inspection standards of WHO, CDSCO (DCGI), and state regulatory authorities. Every injection batch undergoes mandatory sterility testing, bacterial endotoxin testing, and 100% visual inspection before release — non-negotiable quality standards for products administered directly into patients' blood or tissues.

Why Choose Saturn Formulations for Injectable Franchise?

• India's Fastest-Growing Healthcare Sector: India adds 1.5 million new hospital beds annually — each representing captive demand for injectable medications.
• High Per-Unit Revenue: Injectable products command significantly higher MRPs than equivalent oral formulations — maximising franchise partner revenue per therapeutic course.
• Essential Hospital Formulary Products: Antibiotics, analgesics, antiemetics, and IV fluids are mandatory on every hospital formulary — ensuring guaranteed placement in institutional supply agreements.
• WHO-GMP and Schedule M Compliance: The certification foundation required for hospital pharmacy committee product approval and institutional tendering.
• Bulk Institutional Orders: Hospital supply generates large-volume regular orders with predictable monthly invoice values — the most stable franchise revenue model.
• Monopoly Supply Territory: Exclusive hospital and institutional supply rights in your assigned territory.

Our Injectable Product Range

Antibiotic Injections

Ceftriaxone 250mg, 500mg, 1g, and 2g vials — India's most prescribed injectable antibiotic across hospital, nursing home, and clinic settings. Cefuroxime 750mg and 1.5g vials for second-generation cephalosporin IV therapy. Ampicillin + Sulbactam 1.5g and 3g vials for beta-lactamase-stable coverage. Piperacillin + Tazobactam 4.5g vials for hospital-acquired infection management. Meropenem 250mg, 500mg, and 1g vials for carbapenem-tier antibiotic therapy of resistant infections. These injectables are stocked in every hospital dispensary across India.

Analgesic and Anti-Inflammatory Injections

Diclofenac Sodium 25mg/ml (75mg/3ml) injection for acute pain management and post-operative analgesia. Ketorolac 15mg/ml and 30mg/ml injection for short-term moderate-to-severe pain management — the injectable NSAID standard for post-surgical pain. Tramadol 50mg/ml injection for moderate-to-severe acute pain. Buprenorphine 0.3mg/ml injection (Schedule X) for severe pain management in post-operative and oncology settings. Methylprednisolone 40mg, 125mg, and 500mg vials for IV corticosteroid therapy in acute exacerbations and inflammatory emergencies.

Cardiovascular Injections

Furosemide 10mg/ml injection for acute pulmonary oedema and cardiac decompensation. Dopamine 40mg/ml concentrate for IV dilution for cardiogenic shock haemodynamic support. Adrenaline (Epinephrine) 1mg/ml injection for anaphylaxis and cardiac arrest management — an emergency medicine essential. Atropine 0.6mg/ml and 1mg/ml injection for bradycardia and organophosphate poisoning antidote. Heparin Sodium 5000 IU/ml injection for anticoagulation in DVT, PE, and ACS management.

Neurological and Anaesthetic Injections

Diazepam 5mg/ml injection for status epilepticus and pre-operative sedation. Midazolam 1mg/ml and 5mg/ml injection for procedural sedation and anaesthesia induction. Phenytoin Sodium 50mg/ml injection for IV loading in status epilepticus. Lidocaine 1% and 2% injection for local anaesthesia in minor procedures. Bupivacaine 0.25%, 0.5%, and hyperbaric 0.5% for spinal and epidural anaesthesia.

Vitamin and Nutritional Injections

Vitamin B complex injection (B1, B6, B12) for nutritional deficiency and neuropathy management. Vitamin B12 (Methylcobalamin) 500mcg and 1000mcg injection for B12 deficiency neuropathy. Vitamin C 500mg/ml injection for antioxidant high-dose IV therapy. Iron Sucrose 100mg/5ml injection for IV iron replacement in severe anaemia when oral therapy is inadequate. These high-demand supportive care injectables are prescribed across multiple specialties.

Large Volume Parenterals (LVP)

Normal Saline (NS) 0.9% 100ml, 250ml, 500ml, and 1000ml IV bags for fluid and sodium replacement. Dextrose 5%, 10%, and 25% IV infusions for caloric support and hypoglycaemia management. Ringer's Lactate 500ml and 1000ml for balanced crystalloid resuscitation. DNS (Dextrose Normal Saline) 500ml and 1000ml as combined fluid maintenance. Dextrose 5% in Half-Normal Saline for paediatric maintenance fluid therapy. These LVPs are used in every inpatient admission and surgical procedure — generating the highest volume injectable supply requirements.

Sterile Injectable Quality Assurance

Saturn Formulations' sterile manufacturing facility undergoes quarterly environmental monitoring including viable and non-viable particle counts in all classified zones, monthly water system testing (Total Organic Carbon, conductivity, microbial burden), and annual steam steriliser qualification revalidation. Every injection batch undergoes mandatory 14-day sterility test per BP/USP using membrane filtration method, LAL bacterial endotoxin test with validated sensitivity at NMT 0.25 EU/ml for parenteral products, particulate matter testing at 10 micron and 25 micron thresholds, and 100% automated and manual visual inspection for visible particles, cosmetic defects, and container integrity.

Our sterile quality data and Certificate of Analysis are available for hospital pharmacy committee review, NABL testing verification, and CDSCO inspection at any time — supporting our franchise partners' hospital procurement committee applications.

Start Your Injectable Franchise

1. Contact us: +91-8729000609 | enquiry.saturn@gmail.com
2. Share your target hospital and nursing home accounts
3. Submit Drug License (Form 21 sterile/injectable) and GST documents
4. Review institutional pricing and supply agreement terms
5. Begin hospital formulary registration process with Saturn's regulatory support

Saturn Formulations' Injectable Range franchise gives you a premium institutional supply business with certified sterile quality that hospital pharmacy committees trust. Call us: +91-8729000609.